NewsRx

Search our medical news database

Cancer Therapy News and Articles

Return to Library

Recent Cancer Therapy News and Articles


Research Results from University of Glasgow Update Knowledge of Cancer Therapy

2013 JAN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Fresh data on Cancer Therapy are presented in a new report. According to news reporting from Glasgow, United Kingdom, by NewsRx journalists, research stated, "Regulatory T cells (Tregs) are crucial in mediating immune homeostasis and promoting the establishment and maintenance of peripheral tolerance. However, in the context of cancer their role is more complex, and they are thought to contribute to the progress of many tumours."

The news correspondents obtained a quote from the research from the University of Glasgow, "As cancer cells express both self- and tumour-associated antigens, Tregs are key to dampening effector cell responses, and therefore represent one of the main obstacles to effective anti-tumour responses. Suppression mechanisms employed by Tregs are thought to contribute significantly to the failure of current therapies that rely on induction or potentiation of anti-tumour responses. This review will focus on the current evidence supporting the central role of Tregs in establishing tumour-specific tolerance and promoting cancer escape. We outline the mechanisms underlying their suppressive function and discuss the potential routes of Tregs accumulation within the tumour, including enhanced recruitment, in-situ or local proliferation, and de-novo differentiation. In addition, we review some of the cancer treatment strategies that act, at least in part, to eliminate or interfere with the function of Tregs."

According to the news reporters, the research concluded: "The role of Tregs is being recognized increasingly in cancer, and controlling the function of these suppressive cells in the tumour microenvironment without compromising peripheral tolerance represents a significant challenge for cancer therapies."

For more information on this research see: Suppression, subversion and escape: the role of regulatory T cells in cancer progression. Clinical and Experimental Immunology, 2013;171(1):36-45. Clinical and Experimental Immunology can be contacted at: Wiley-Blackwell, 111 River St, Hoboken 07030-5774, NJ, USA. (Wiley-Blackwell - www.wiley.com/; Clinical and Experimental Immunology - onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2249)

Our news journalists report that additional information may be obtained by contacting K. Oleinika, University of Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Chemokine Res Grp, Glasgow G12 8TA, Lanark, United Kingdom.

Keywords for this news article include: Europe, Glasgow, Oncology, United Kingdom, Cancer Therapy

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook